Civic Intelligence

Pbd Project

EIN 84-5028341 • 501(c)3 • Bethesda, MD

Profile

Research and Funding of Innovative Therapies for PBD

6829 Wilson LaneBethesda, MD 20817

https//pbdproject.org

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

60th percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Liabilities / Revenue

62nd percentile

0.00x

Tied with the lowest-debt nonprofits in its peer group.

501(c)3 • <$500k nonprofits • Source year 2024

Net Margin

93rd percentile

67%

Higher net margin than 93% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2024

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2024

Asset Growth

90th percentile

80%

Faster asset growth than 90% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Revenue Growth

89th percentile

82%

Faster revenue growth than 89% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2023 to 2024

Balance Sheet
Liabilities / Assets60th percentile

Assets

Up

$159,239

Up $70,831 (+80%) from 2023

Liabilities

Flat

$0

Flat from 2023

Net Assets

$159,239

No earlier filing loaded for comparison.

Operations
Liabilities / Revenue62nd percentileNet Margin93rd percentile

Revenue

Up

$105,263

Up $47,420 (+82%) from 2023

Expenses

Down

$34,432

Down $184,957 (-84%) from 2023

Net Income

Up

$70,831

Up $232,377 (+144%) from 2023

Trend Graphs

Balance Sheet Trend

Asset Growth90th percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$300K$200K$100K$0Assets 2020: $161,089Net Assets 2020: $161,0892020Assets 2021: $187,102Net Assets 2021: $187,1022021Assets 2022: $249,954Liabilities 2022: $02022Assets 2023: $88,408Liabilities 2023: $02023Assets 2024: $159,239Liabilities 2024: $0Net Assets 2024: $159,2392024

Highlighted filing

2024

Assets$159,239
Liabilities$0
Net Assets$159,239
Open 2024 Filing

Operations Trend

Revenue Growth89th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$300K$200K$100K$0-$100K-$200KRevenue 2020: $181,341Expenses 2020: $20,252Net Income 2020: $161,0892020Revenue 2021: $103,083Expenses 2021: $77,070Net Income 2021: $26,0132021Revenue 2022: $92,846Expenses 2022: $29,994Net Income 2022: $62,8522022Revenue 2023: $57,843Expenses 2023: $219,389Net Income 2023: -$161,5462023Revenue 2024: $105,263Expenses 2024: $34,432Net Income 2024: $70,8312024

Highlighted filing

2024

Revenue$105,263
Expenses$34,432
Net Income$70,831
Open 2024 Filing

Filings

Most recent year

2024 • Form 990EZXML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$159,239
Liabilities
$0
Net assets
$159,239
Revenue
$105,263
Expenses
$34,432
Net income
$70,831
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2024XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.59$0.00$1.59$1.05$0.34$0.71
2023Summary only. Only limited summary data is available for this year.$0.88$0.00$0.58$2.19$1.62
2022Summary only. Only limited summary data is available for this year.$2.50$0.00$0.93$0.30$0.63
2021XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$1.87$1.87$1.03$0.77$0.26
2020Detailed filing. Detailed filing data is available for this year.$1.61$1.61$1.81$0.20$1.61
Latest Detailed Filing

The latest 2024 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2020 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2020 to Dec 31, 2020
Signed
Nov 11, 2021
Return Version
2020v4.1
Gross Receipts
$181,341
Mission and Program Overview

Mission

Research and Funding of Innovative Therapies for PBD

Program Services

DescriptionGrantsExpenses
Collaboration with Rarebase, PBC https//www.rarebase.org/ as technical consultant for technical expertise on developing a drug discovery platform for genetic diseases.-$9,300
Collaboration with Natalia Morsci as technical consultant for technical expertise on sundry PEX10 program efforts, including RD strategy, drug repurposing screens, and assay development.-$9,187
Collaboration with NemaMetrix, Inc. for the creation of C. elegans model with PEX10 mutation.-$1,750
Compensation and Service Providers
Top Officer Pay81st percentile

Employees

NameTitleFull / Part TimeBaseOtherTotal
Andrew LongeneckerPresidentPT$0--
Maria RetanaVice-PresidentPT$0--
Duncan MackayTreasurer-$0--
Francisco SanchezSecretary-$0--
Filing and Contact Details

Filer

Filer Name
PBD Project
EIN
84-5028341
Phone
5613583023
Address
6829 Wilson Lane, Bethesda, MD 20817

Signing Officer

Name
Andrew Longenecker
Title
President
Signed
2021-11-11
Discuss with paid preparer
Yes

Preparer

Firm
Foundation Group Inc
Address
2451 Atrium Way Suite 300, Nashville, TN 37214
Preparer
William G McRay
Phone
6153619445
Supplemental Narrative

Additional Explanations

Form 990-EZ, Part I, Line 16, Other Expenses

“Program Expense Research Collaboration -- C. Elegans Model 1,750”

Form 990-EZ, Part I, Line 16, Other Expenses

“Program Expense Technical Consultants 18,487”

Form 990-EZ, Part I, Line 16, Other Expenses

“Bank Service Charges 15”

Raw XML Appendix129 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/AddressChangeInd0X
IRS990EZ/BooksInCareOfDetail/PersonNm0Andrew Longenecker
IRS990EZ/BooksInCareOfDetail/PhoneNum05613583023
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt06829 Wilson Lane
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0Bethesda
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MD
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd020817
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt0161089
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0false
IRS990EZ/ContributionsGiftsGrantsEtcAmt0181341
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0161089
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt00
IRS990EZ/Form990TotalAssetsGrp/EOYAmt0161089
IRS990EZ/GrossReceiptsAmt0181341
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InitialReturnInd0X
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0false
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0161089
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt00
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0161089
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0020.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1020.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2001.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3001.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0Andrew Longenecker
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1Maria Retana
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2Duncan Mackay
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3Francisco Sanchez
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1Vice-President
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2Treasurer
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3Secretary
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt020252
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt0Research and Funding of Innovative Therapies for PBD
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0Collaboration with NemaMetrix, Inc. for the creation of C. elegans model with PEX10 mutation.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt1Collaboration with Natalia Morsci as technical consultant for technical expertise on sundry PEX10 program efforts, including RD strategy, drug repurposing screens, and assay development.
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt2Collaboration with Rarebase, PBC https//www.rarebase.org/ as technical consultant for technical expertise on developing a drug discovery platform for genetic diseases.
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt01750
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt19187
IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt29300
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/StatesWhereCopyOfReturnIsFldCd0DE
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TaxImposedUnderIRC4911Amt00
IRS990EZ/TaxImposedUnderIRC4912Amt00
IRS990EZ/TaxImposedUnderIRC4955Amt00
IRS990EZ/TotalExpensesAmt020252
IRS990EZ/TotalProgramServiceExpensesAmt020237
IRS990EZ/TotalRevenueAmt0181341
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0https//pbdproject.org/
IRS990ScheduleA/First5Years170Ind0X
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/CurrentTaxYearAmt0181341
IRS990ScheduleA/GiftsGrantsContriRcvd170Grp/TotalAmt0181341
IRS990ScheduleA/PublicOrganization170Ind0X
IRS990ScheduleA/PublicSupportCY170Pct00.00000
IRS990ScheduleA/PublicSupportTotal170Amt0181341
IRS990ScheduleA/TotalCalendarYear170Grp/CurrentTaxYearAmt0181341
IRS990ScheduleA/TotalCalendarYear170Grp/TotalAmt0181341
IRS990ScheduleA/TotalSupportAmt0181341
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0Program Expense Research Collaboration -- C. Elegans Model 1,750
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1Program Expense Technical Consultants 18,487
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2Bank Service Charges 15
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0Form 990-EZ, Part I, Line 16, Other Expenses
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1Form 990-EZ, Part I, Line 16, Other Expenses
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2Form 990-EZ, Part I, Line 16, Other Expenses
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/AuthenticationAssuranceLevelCd0AAL1
ReturnHeader/AdditionalFilerInformation/TrustedCustomerGrp/IdentityAssuranceLevelCd0IAL1
ReturnHeader/BuildTS02022-09-23 18:48:47Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0Andrew Longenecker
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0President
ReturnHeader/BusinessOfficerGrp/SignatureDt02021-11-11
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0PBD Project
ReturnHeader/Filer/BusinessNameControlTxt0PBDP
ReturnHeader/Filer/EIN0845028341
ReturnHeader/Filer/PhoneNum05613583023
ReturnHeader/Filer/USAddress/AddressLine1Txt06829 Wilson Lane
ReturnHeader/Filer/USAddress/CityNm0Bethesda
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MD
ReturnHeader/Filer/USAddress/ZIPCd020817
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0Foundation Group Inc
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt02451 Atrium Way Suite 300
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0Nashville
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0TN
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd037214
ReturnHeader/PreparerPersonGrp/PhoneNum06153619445
ReturnHeader/PreparerPersonGrp/PreparationDt02021-11-11
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0William G McRay
ReturnHeader/ReturnTs02021-11-11T09:15:03-00:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm0Andrew
ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm0Longenecker
ReturnHeader/TaxPeriodBeginDt02020-01-01
ReturnHeader/TaxPeriodEndDt02020-12-31
ReturnHeader/TaxYr02020

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Peer Organizations

Similar nonprofits based on the same Siviq industry and scale cohort. 501(c)3 • <$500k nonprofits